Inventor

Steven A. Goldman

Inventor
Webster, NY, US

Overview

36→
Patents
1981–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 36 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C12NMicroorganisms or enzymes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
A01KAnimal husbandry5%
Y02ATechnologies for adaptation to climate change4%
A61LMethods or apparatus for sterilising materials or objects in general3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
A61BDiagnosis1%
A61FFilters implantable into blood vessels1%
PatentTitleYear
11,020,510Muscle cell patches and uses therefor202110,856,938Cardiac electrophysiologic mapping and stimulation202010,779,519Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathy202010,626,369Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders202010,485,807Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells201910,450,546Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders201910,279,051Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder201910,190,095Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells201910,172,976Muscle cell patches and uses therefor20199,724,432'Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder'20179,709,553'Treating myelin diseases with optimized cell preparations'20179,371,513'Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells'20168,945,921'Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells'20158,642,332'Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain'20148,524,499'Regulatory sequences that direct gene expression to spinal motor neurons and uses thereof'20138,399,518'Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome'20138,263,406'Enriched or purified population of motor neurons and its preparation from a population of embryonic stem cells'20128,263,402'Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells'20128,206,699'Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells'20127,923,448'Purine receptor inhibition as a therapeutic strategy in spinal cord and brain'20117,829,332'Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom'20107,807,145'Method of inducing neuronal production in the brain and spinal cord'20107,803,752'Method of inducing neuronal production in the caudate nucleus and putamen'20107,785,882'Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying them'20107,576,065'Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein'20097,524,491'Non human animals with human-glial chimeric brains'20097,504,435'Method for stimulating weight loss and/or for lowering triglycerides in patients'20097,468,277'Enriched preparation of human fetal multipotential neural stem cells'20087,150,989'Telomerase immortalized neural progenitor cells'20067,037,493'Method of inducing neuronal production in the brain and spinal cord'20066,812,027'Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain'20046,692,957'Method for separating cells'20046,534,676'Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same'20036,245,564'Method for separating cells'20015,998,695'Absorbent article including ionic complexing agent for feces'19994,257,747'Monitoring machinery by detecting vibrations'1981

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1981Based in West Nyack, NY, US· patent location history
1999Based in Cincinnati, OH, US· patent location history
2001–2019Patents assigned to CORNELL RES FOUNDATION INC (21)· patent assignee history
2001–2012Based in South Salem, NY, US· patent location history
2003–2021Patents assigned to UNIV ARIZONA (5)· patent assignee history
2003–2021Based in Tucson, AZ, US· patent location history
2009–2020Patents assigned to UNIV ROCHESTER (7)· patent assignee history
2009–2020Based in Webster, NY, US· patent location history
2012–2017Patents assigned to GOLDMAN STEVEN A (8)· patent assignee history
2012–2016Patents assigned to ROY NEETA SINGH (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CORNELL RES FOUNDATION INC212001–2019
GOLDMAN STEVEN Aself82012–2017
UNIV ROCHESTER72009–2020
UNIV ARIZONA52003–2021
ROY NEETA SINGH42012–2016
Locations
LocationPatentsSpan
Webster, New York, US192009–2020
South Salem, New York, US92001–2012
Tucson, AZ, US62003–2021
Cincinnati, OH, US11999
West Nyack, New York, US11981